Endogenous retrovirus envelope as a tumor-associated immunotherapeutic target in murine osteosarcoma-Reference-Cited by-同舟云学术

Endogenous retrovirus envelope as a tumor-associated immunotherapeutic target in murine osteosarcoma

Published:2021-07 Issue:7 Volume:24 Page:102759
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Wedekind Mary Frances,Miller Katherine E.,Chen Chun-Yu,Wang Pin-Yi,Hutzen Brian J.,Currier Mark A.^ORCID,Nartker Brooke,Roberts Ryan D.,Boon Louis,Conner Joe,LaHaye Stephanie,Kelly Benjamin J.^ORCID,Gordon David^ORCID,White Peter,Mardis Elaine R.,Cripe Timothy P.

Funder

National Cancer Institute

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference58 articles.

1. Cancer associated endogenous retroviruses: ideal immune targets for adenovirus-based immunotherapy;Bermejo;Int. J. Mol. Sci.,2020

2. Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden;Chalmers;Genome Med.,2017

3. Oncolytic virus and PD-1/PD-L1 blockade combination therapy;Chen;Oncolytic Virother.,2018

4. Cooperation of oncolytic herpes virotherapy and PD-1 blockade in murine rhabdomyosarcoma models;Chen;Sci. Rep.,2017

5. Inference of immune cell composition on the expression profiles of mouse tissue;Chen;Sci. Rep.,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncolytic Viral Therapy in Osteosarcoma;Viruses;2024-07-16

2. Myelomodulatory treatments augment the therapeutic benefit of oncolytic viroimmunotherapy in murine models of malignant peripheral nerve sheath tumors;Frontiers in Immunology;2024-06-25

3. Galectin-3 inhibition boosts the therapeutic efficacy of Semliki Forest virus in pediatric osteosarcoma;Molecular Therapy - Oncolytics;2022-09